-
公开(公告)号:US20170100606A1
公开(公告)日:2017-04-13
申请号:US15289574
申请日:2016-10-10
发明人: Lothar LILGE , Arkady MANDEL , Wayne EMBREE , Kai ZHANG , Don LEM , Jenny WU , Roger DUMOULIN-WHITE
CPC分类号: A61N5/062 , A61B5/0084 , A61B5/202 , A61B5/4839 , A61B5/6858 , A61B90/30 , A61B2090/306 , A61M25/0074 , A61M2205/3306 , A61M2210/1085 , A61N2005/061 , A61N2005/063
摘要: Apparatus for illuminating comprises one or more fibers, the one or more fibers including fiber portions meeting at an apex and a bottom location to form a three dimensional cage; a detector attached to each of the fiber portions for receiving light and transmitting light along each of the fiber portions, respectively; and an illumination member situated within the cage. A method for illuminating a hollow member includes the steps of inserting one or more fibers into the hollow member, wherein one or more fibers include fiber portions that meet at a location to form a three-dimensional cage; permitting light to emit from within the three-dimensional cage and towards the fiber portions; receiving light at distinct locations on each of said fibers; and allowing each of the fibers to transmit the light received on each of the fiber portions out of the hollow member.
-
公开(公告)号:US20190290657A1
公开(公告)日:2019-09-26
申请号:US16365148
申请日:2019-03-26
IPC分类号: A61K31/555 , A61K31/352 , A61K47/64 , A61K41/00
摘要: Disclosed is a method for treating a condition associated with hyperproliferating cells, the method including the steps of administering to a subject having the condition a composition including at least one cannabinoid receptor agonist, optionally administering to the subject a photodynamic compound, and administering radiation to the subject in whom the at least one cannabinoid receptor agonist is present so as to treat the condition.
-
公开(公告)号:US20220280529A1
公开(公告)日:2022-09-08
申请号:US17192597
申请日:2021-03-04
IPC分类号: A61K31/555 , A61K39/125
摘要: A method for eliciting an immune response in a patient includes the sequential steps of: providing an immunogenic composition including an immunogen; adding a metal-based coordination complex to the immunogenic composition to inactivate or attenuate the immunogen; and administering the immunogenic composition to the patient so as to elicit the immune response against the immunogen. A method for preparing an attenuated immunogenic composition includes the steps of: providing an immunogenic composition including an immunogen; and adding a metal-based coordination complex to the immunogenic composition to inactivate or attenuate the immunogen in the immunogenic composition to provide the attenuated immunogenic composition.
-
-